APO Research
Talk to an analyst

APO RESEARCH · REPORT

EPA & DHA Omega-3

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global EPA & DHA Omega-3 Market Outlook and Growth Opportunities 2026

19 December 2025215 pages

Choose your research edition.

Industry ResearchEPA & DHA Omega-3 Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal EPA & DHA Omega-3 Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal EPA & DHA Omega-3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EPA & DHA Omega-3 Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal EPA & DHA Omega-3 Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global EPA & DHA Omega-3 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for EPA & DHA Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for EPA & DHA Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EPA & DHA Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the EPA & DHA Omega-3 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the EPA & DHA Omega-3 market include Shandong Yuwang Pharmaceutical, Xinzhou, TASA, Solutex, Skuny, Sinomega, Polaris, Orkla Health and Omega Protein, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global EPA & DHA Omega-3 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of EPA & DHA Omega-3 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents EPA & DHA Omega-3 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the EPA & DHA Omega-3 market size, projected growth trends, production technologies, key applications, and end-use industries.

EPA & DHA Omega-3 Segment by Company

Shandong Yuwang Pharmaceutical

Xinzhou

TASA

Solutex

Skuny

Sinomega

Polaris

Orkla Health

Omega Protein

OLVEA Fish Oils

Nippon Suisan Kaisha

Maruha Nichiro Foods

Marine Ingredients

LYSI

Kinomega

KD Pharma

Hofseth BioCare

Golden Omega

GC Rieber

EPAX

DSM

Croda

Bioprocess Algae

BASF

Auqi

Anti-Cancer

EPA & DHA Omega-3 Segment by Type

Marine Animals Source Omega-3

Marine Plant Source Omega-3

EPA & DHA Omega-3 Segment by Application

Pet Foods

Fortified Food and Beverage

Dietary Supplements

Pharmaceuticals

Infant Formula

Others

EPA & DHA Omega-3 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global EPA & DHA Omega-3 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions EPA & DHA Omega-3 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify EPA & DHA Omega-3 significant trends, drivers, influence factors in global and regions.

6. To analyze EPA & DHA Omega-3 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA & DHA Omega-3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EPA & DHA Omega-3 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA & DHA Omega-3.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the EPA & DHA Omega-3 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global EPA & DHA Omega-3 industry.

Chapter 3: Detailed analysis of EPA & DHA Omega-3 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of EPA & DHA Omega-3 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of EPA & DHA Omega-3 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. EPA & DHA Omega-3 Industry Trends Table 2. EPA & DHA Omega-3 Industry Drivers Table 3. EPA & DHA Omega-3 Industry Opportunities and Challenges Table 4. EPA & DHA Omega-3 Industry Restraints Table 5. Global EPA & DHA Omega-3 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global EPA & DHA Omega-3 Revenue Share by Company (2021-2026) Table 7. Global EPA & DHA Omega-3 Sales Volume by Company (K Tons) & (2021-2026) Table 8. Global EPA & DHA Omega-3 Sales Volume Share by Company (2021-2026) Table 9. Global EPA & DHA Omega-3 Average Price (US$/Ton) of Company (2021-2026) Table 10. Global EPA & DHA Omega-3 Company Ranking, (2024-2026) & (USD Million) Table 11. Global EPA & DHA Omega-3 Key Company Manufacturing Base & Headquarters Table 12. Global EPA & DHA Omega-3 Company, Product Type & Application Table 13. Global EPA & DHA Omega-3 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global EPA & DHA Omega-3 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Marine Animals Source Omega-3 Table 18. Significant Companies of Marine Plant Source Omega-3 Table 19. Global EPA & DHA Omega-3 Sales Volume by Type 2021 VS 2025 VS 2032 (K Tons) Table 20. Global EPA & DHA Omega-3 Sales Volume by Type (2021-2026) & (K Tons) Table 21. Global EPA & DHA Omega-3 Sales Volume by Type (2027-2032) & (K Tons) Table 22. Global EPA & DHA Omega-3 Sales Volume Share by Type (2021-2026) Table 23. Global EPA & DHA Omega-3 Sales Volume Share by Type (2027-2032) Table 24. Global EPA & DHA Omega-3 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global EPA & DHA Omega-3 Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global EPA & DHA Omega-3 Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global EPA & DHA Omega-3 Sales Value Share by Type (2021-2026) Table 28. Global EPA & DHA Omega-3 Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pet Foods Table 30. Significant Companies of Fortified Food and Beverage Table 31. Significant Companies of Dietary Supplements Table 32. Significant Companies of Pharmaceuticals Table 33. Significant Companies of Infant Formula Table 34. Significant Companies of Others Table 35. Global EPA & DHA Omega-3 Sales Volume by Application 2021 VS 2025 VS 2032 (K Tons) Table 36. Global EPA & DHA Omega-3 Sales Volume by Application (2021-2026) & (K Tons) Table 37. Global EPA & DHA Omega-3 Sales Volume by Application (2027-2032) & (K Tons) Table 38. Global EPA & DHA Omega-3 Sales Volume Share by Application (2021-2026) Table 39. Global EPA & DHA Omega-3 Sales Volume Share by Application (2027-2032) Table 40. Global EPA & DHA Omega-3 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global EPA & DHA Omega-3 Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global EPA & DHA Omega-3 Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global EPA & DHA Omega-3 Sales Value Share by Application (2021-2026) Table 44. Global EPA & DHA Omega-3 Sales Value Share by Application (2027-2032) Table 45. Global EPA & DHA Omega-3 Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 46. Global EPA & DHA Omega-3 Sales by Region (2021-2026) & (K Tons) Table 47. Global EPA & DHA Omega-3 Sales Market Share by Region (2021-2026) Table 48. Global EPA & DHA Omega-3 Sales by Region (2027-2032) & (K Tons) Table 49. Global EPA & DHA Omega-3 Sales Market Share by Region (2027-2032) Table 50. Global EPA & DHA Omega-3 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global EPA & DHA Omega-3 Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global EPA & DHA Omega-3 Sales Value Share by Region (2021-2026) Table 53. Global EPA & DHA Omega-3 Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global EPA & DHA Omega-3 Sales Value Share by Region (2027-2032) Table 55. Global EPA & DHA Omega-3 Market Average Price (US$/Ton) by Region (2021-2026) Table 56. Global EPA & DHA Omega-3 Market Average Price (US$/Ton) by Region (2027-2032) Table 57. Global EPA & DHA Omega-3 Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Table 58. Global EPA & DHA Omega-3 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 60. Global EPA & DHA Omega-3 Sales Market Share by Country (2021-2026) Table 61. Global EPA & DHA Omega-3 Sales by Country (2027-2032) & (K Tons) Table 62. Global EPA & DHA Omega-3 Sales Market Share by Country (2027-2032) Table 63. Global EPA & DHA Omega-3 Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global EPA & DHA Omega-3 Sales Value Market Share by Country (2021-2026) Table 65. Global EPA & DHA Omega-3 Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global EPA & DHA Omega-3 Sales Value Market Share by Country (2027-2032) Table 67. Shandong Yuwang Pharmaceutical Company Information Table 68. Shandong Yuwang Pharmaceutical Business Overview Table 69. Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Product Portfolio Table 71. Shandong Yuwang Pharmaceutical Recent Development Table 72. Xinzhou Company Information Table 73. Xinzhou Business Overview Table 74. Xinzhou EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Xinzhou EPA & DHA Omega-3 Product Portfolio Table 76. Xinzhou Recent Development Table 77. TASA Company Information Table 78. TASA Business Overview Table 79. TASA EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. TASA EPA & DHA Omega-3 Product Portfolio Table 81. TASA Recent Development Table 82. Solutex Company Information Table 83. Solutex Business Overview Table 84. Solutex EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Solutex EPA & DHA Omega-3 Product Portfolio Table 86. Solutex Recent Development Table 87. Skuny Company Information Table 88. Skuny Business Overview Table 89. Skuny EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Skuny EPA & DHA Omega-3 Product Portfolio Table 91. Skuny Recent Development Table 92. Sinomega Company Information Table 93. Sinomega Business Overview Table 94. Sinomega EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Sinomega EPA & DHA Omega-3 Product Portfolio Table 96. Sinomega Recent Development Table 97. Polaris Company Information Table 98. Polaris Business Overview Table 99. Polaris EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Polaris EPA & DHA Omega-3 Product Portfolio Table 101. Polaris Recent Development Table 102. Orkla Health Company Information Table 103. Orkla Health Business Overview Table 104. Orkla Health EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Orkla Health EPA & DHA Omega-3 Product Portfolio Table 106. Orkla Health Recent Development Table 107. Omega Protein Company Information Table 108. Omega Protein Business Overview Table 109. Omega Protein EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Omega Protein EPA & DHA Omega-3 Product Portfolio Table 111. Omega Protein Recent Development Table 112. OLVEA Fish Oils Company Information Table 113. OLVEA Fish Oils Business Overview Table 114. OLVEA Fish Oils EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. OLVEA Fish Oils EPA & DHA Omega-3 Product Portfolio Table 116. OLVEA Fish Oils Recent Development Table 117. Nippon Suisan Kaisha Company Information Table 118. Nippon Suisan Kaisha Business Overview Table 119. Nippon Suisan Kaisha EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 120. Nippon Suisan Kaisha EPA & DHA Omega-3 Product Portfolio Table 121. Nippon Suisan Kaisha Recent Development Table 122. Maruha Nichiro Foods Company Information Table 123. Maruha Nichiro Foods Business Overview Table 124. Maruha Nichiro Foods EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 125. Maruha Nichiro Foods EPA & DHA Omega-3 Product Portfolio Table 126. Maruha Nichiro Foods Recent Development Table 127. Marine Ingredients Company Information Table 128. Marine Ingredients Business Overview Table 129. Marine Ingredients EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 130. Marine Ingredients EPA & DHA Omega-3 Product Portfolio Table 131. Marine Ingredients Recent Development Table 132. LYSI Company Information Table 133. LYSI Business Overview Table 134. LYSI EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 135. LYSI EPA & DHA Omega-3 Product Portfolio Table 136. LYSI Recent Development Table 137. Kinomega Company Information Table 138. Kinomega Business Overview Table 139. Kinomega EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 140. Kinomega EPA & DHA Omega-3 Product Portfolio Table 141. Kinomega Recent Development Table 142. KD Pharma Company Information Table 143. KD Pharma Business Overview Table 144. KD Pharma EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 145. KD Pharma EPA & DHA Omega-3 Product Portfolio Table 146. KD Pharma Recent Development Table 147. Hofseth BioCare Company Information Table 148. Hofseth BioCare Business Overview Table 149. Hofseth BioCare EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 150. Hofseth BioCare EPA & DHA Omega-3 Product Portfolio Table 151. Hofseth BioCare Recent Development Table 152. Golden Omega Company Information Table 153. Golden Omega Business Overview Table 154. Golden Omega EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 155. Golden Omega EPA & DHA Omega-3 Product Portfolio Table 156. Golden Omega Recent Development Table 157. GC Rieber Company Information Table 158. GC Rieber Business Overview Table 159. GC Rieber EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 160. GC Rieber EPA & DHA Omega-3 Product Portfolio Table 161. GC Rieber Recent Development Table 162. EPAX Company Information Table 163. EPAX Business Overview Table 164. EPAX EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 165. EPAX EPA & DHA Omega-3 Product Portfolio Table 166. EPAX Recent Development Table 167. DSM Company Information Table 168. DSM Business Overview Table 169. DSM EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 170. DSM EPA & DHA Omega-3 Product Portfolio Table 171. DSM Recent Development Table 172. Croda Company Information Table 173. Croda Business Overview Table 174. Croda EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 175. Croda EPA & DHA Omega-3 Product Portfolio Table 176. Croda Recent Development Table 177. Bioprocess Algae Company Information Table 178. Bioprocess Algae Business Overview Table 179. Bioprocess Algae EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 180. Bioprocess Algae EPA & DHA Omega-3 Product Portfolio Table 181. Bioprocess Algae Recent Development Table 182. BASF Company Information Table 183. BASF Business Overview Table 184. BASF EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 185. BASF EPA & DHA Omega-3 Product Portfolio Table 186. BASF Recent Development Table 187. Auqi Company Information Table 188. Auqi Business Overview Table 189. Auqi EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 190. Auqi EPA & DHA Omega-3 Product Portfolio Table 191. Auqi Recent Development Table 192. Anti-Cancer Company Information Table 193. Anti-Cancer Business Overview Table 194. Anti-Cancer EPA & DHA Omega-3 Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 195. Anti-Cancer EPA & DHA Omega-3 Product Portfolio Table 196. Anti-Cancer Recent Development Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. EPA & DHA Omega-3 Distributors List Table 200. EPA & DHA Omega-3 Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. EPA & DHA Omega-3 Product Image Figure 2. Global EPA & DHA Omega-3 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EPA & DHA Omega-3 Sales Value (2021-2032) & (US$ Million) Figure 4. Global EPA & DHA Omega-3 Sales (2021-2032) & (K Tons) Figure 5. Global EPA & DHA Omega-3 Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global EPA & DHA Omega-3 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Marine Animals Source Omega-3 Image Figure 10. Marine Plant Source Omega-3 Image Figure 11. Global EPA & DHA Omega-3 Sales Volume by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 12. Global EPA & DHA Omega-3 Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global EPA & DHA Omega-3 Sales Volume Share by Type (2021-2032) Figure 14. Global EPA & DHA Omega-3 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global EPA & DHA Omega-3 Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global EPA & DHA Omega-3 Sales Value Share by Type (2021-2032) Figure 17. Pet Foods Image Figure 18. Fortified Food and Beverage Image Figure 19. Dietary Supplements Image Figure 20. Pharmaceuticals Image Figure 21. Infant Formula Image Figure 22. Others Image Figure 23. Global EPA & DHA Omega-3 Sales Volume by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 24. Global EPA & DHA Omega-3 Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global EPA & DHA Omega-3 Sales Volume Share by Application (2021-2032) Figure 26. Global EPA & DHA Omega-3 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global EPA & DHA Omega-3 Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global EPA & DHA Omega-3 Sales Value Share by Application (2021-2032) Figure 29. Global EPA & DHA Omega-3 Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 30. Global EPA & DHA Omega-3 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global EPA & DHA Omega-3 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global EPA & DHA Omega-3 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America EPA & DHA Omega-3 Sales Value (2021-2032) & (US$ Million) Figure 34. North America EPA & DHA Omega-3 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe EPA & DHA Omega-3 Sales Value (2021-2032) & (US$ Million) Figure 36. Europe EPA & DHA Omega-3 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific EPA & DHA Omega-3 Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific EPA & DHA Omega-3 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America EPA & DHA Omega-3 Sales Value (2021-2032) & (US$ Million) Figure 40. South America EPA & DHA Omega-3 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa EPA & DHA Omega-3 Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa EPA & DHA Omega-3 Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. EPA & DHA Omega-3 Value Chain Figure 128. Manufacturing Cost Structure Figure 129. EPA & DHA Omega-3 Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Marine Animals Source Omega-3
  • Marine Plant Source Omega-3
Applications
  • Pet Foods
  • Fortified Food and Beverage
  • Dietary Supplements
  • Pharmaceuticals
  • Infant Formula
  • Others
Companies covered
  • Shandong Yuwang Pharmaceutical
  • Xinzhou
  • TASA
  • Solutex
  • Skuny
  • Sinomega
  • Polaris
  • Orkla Health
  • Omega Protein
  • OLVEA Fish Oils
  • Nippon Suisan Kaisha
  • Maruha Nichiro Foods
  • Marine Ingredients
  • LYSI
  • Kinomega
  • KD Pharma
  • Hofseth BioCare
  • Golden Omega
  • GC Rieber
  • EPAX
  • DSM
  • Croda
  • Bioprocess Algae
  • BASF
  • Auqi
  • Anti-Cancer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global EPA & DHA Omega-3 Sales Value (2021-2032)
  4. 1.2.2 Global EPA & DHA Omega-3 Sales Volume (2021-2032)
  5. 1.2.3 Global EPA & DHA Omega-3 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 EPA & DHA Omega-3 Market Dynamics
  1. 2.1 EPA & DHA Omega-3 Industry Trends
  2. 2.2 EPA & DHA Omega-3 Industry Drivers
  3. 2.3 EPA & DHA Omega-3 Industry Opportunities and Challenges
  4. 2.4 EPA & DHA Omega-3 Industry Restraints
3 EPA & DHA Omega-3 Market by Company
  1. 3.1 Global EPA & DHA Omega-3 Company Revenue Ranking in 2025
  2. 3.2 Global EPA & DHA Omega-3 Revenue by Company (2021-2026)
  3. 3.3 Global EPA & DHA Omega-3 Sales Volume by Company (2021-2026)
  4. 3.4 Global EPA & DHA Omega-3 Average Price by Company (2021-2026)
  5. 3.5 Global EPA & DHA Omega-3 Company Ranking (2024-2026)
  6. 3.6 Global EPA & DHA Omega-3 Company Manufacturing Base and Headquarters
  7. 3.7 Global EPA & DHA Omega-3 Company Product Type and Application
  8. 3.8 Global EPA & DHA Omega-3 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global EPA & DHA Omega-3 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 EPA & DHA Omega-3 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 EPA & DHA Omega-3 Market by Type
  1. 4.1 EPA & DHA Omega-3 Type Introduction
  2. 4.1.1 Marine Animals Source Omega-3
  3. 4.1.2 Marine Plant Source Omega-3
  4. 4.2 Global EPA & DHA Omega-3 Sales Volume by Type
  5. 4.2.1 Global EPA & DHA Omega-3 Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global EPA & DHA Omega-3 Sales Volume by Type (2021-2032)
  7. 4.2.3 Global EPA & DHA Omega-3 Sales Volume Share by Type (2021-2032)
  8. 4.3 Global EPA & DHA Omega-3 Sales Value by Type
  9. 4.3.1 Global EPA & DHA Omega-3 Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global EPA & DHA Omega-3 Sales Value by Type (2021-2032)
  11. 4.3.3 Global EPA & DHA Omega-3 Sales Value Share by Type (2021-2032)
5 EPA & DHA Omega-3 Market by Application
  1. 5.1 EPA & DHA Omega-3 Application Introduction
  2. 5.1.1 Pet Foods
  3. 5.1.2 Fortified Food and Beverage
  4. 5.1.3 Dietary Supplements
  5. 5.1.4 Pharmaceuticals
  6. 5.1.5 Infant Formula
  7. 5.1.6 Others
  8. 5.2 Global EPA & DHA Omega-3 Sales Volume by Application
  9. 5.2.1 Global EPA & DHA Omega-3 Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global EPA & DHA Omega-3 Sales Volume by Application (2021-2032)
  11. 5.2.3 Global EPA & DHA Omega-3 Sales Volume Share by Application (2021-2032)
  12. 5.3 Global EPA & DHA Omega-3 Sales Value by Application
  13. 5.3.1 Global EPA & DHA Omega-3 Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global EPA & DHA Omega-3 Sales Value by Application (2021-2032)
  15. 5.3.3 Global EPA & DHA Omega-3 Sales Value Share by Application (2021-2032)
6 EPA & DHA Omega-3 Regional Sales and Value Analysis
  1. 6.1 Global EPA & DHA Omega-3 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global EPA & DHA Omega-3 Sales by Region (2021-2032)
  3. 6.2.1 Global EPA & DHA Omega-3 Sales by Region: 2021-2026
  4. 6.2.2 Global EPA & DHA Omega-3 Sales by Region (2027-2032)
  5. 6.3 Global EPA & DHA Omega-3 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global EPA & DHA Omega-3 Sales Value by Region (2021-2032)
  7. 6.4.1 Global EPA & DHA Omega-3 Sales Value by Region: 2021-2026
  8. 6.4.2 Global EPA & DHA Omega-3 Sales Value by Region (2027-2032)
  9. 6.5 Global EPA & DHA Omega-3 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America EPA & DHA Omega-3 Sales Value (2021-2032)
  12. 6.6.2 North America EPA & DHA Omega-3 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe EPA & DHA Omega-3 Sales Value (2021-2032)
  15. 6.7.2 Europe EPA & DHA Omega-3 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific EPA & DHA Omega-3 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific EPA & DHA Omega-3 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America EPA & DHA Omega-3 Sales Value (2021-2032)
  21. 6.9.2 South America EPA & DHA Omega-3 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa EPA & DHA Omega-3 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa EPA & DHA Omega-3 Sales Value Share by Country, 2025 VS 2032
7 EPA & DHA Omega-3 Country-level Sales and Value Analysis
  1. 7.1 Global EPA & DHA Omega-3 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global EPA & DHA Omega-3 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global EPA & DHA Omega-3 Sales by Country (2021-2032)
  4. 7.3.1 Global EPA & DHA Omega-3 Sales by Country (2021-2026)
  5. 7.3.2 Global EPA & DHA Omega-3 Sales by Country (2027-2032)
  6. 7.4 Global EPA & DHA Omega-3 Sales Value by Country (2021-2032)
  7. 7.4.1 Global EPA & DHA Omega-3 Sales Value by Country (2021-2026)
  8. 7.4.2 Global EPA & DHA Omega-3 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt EPA & DHA Omega-3 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt EPA & DHA Omega-3 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt EPA & DHA Omega-3 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shandong Yuwang Pharmaceutical
  2. 8.1.1 Shandong Yuwang Pharmaceutical Company Information
  3. 8.1.2 Shandong Yuwang Pharmaceutical Business Overview
  4. 8.1.3 Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Product Portfolio
  6. 8.1.5 Shandong Yuwang Pharmaceutical Recent Developments
  7. 8.2 Xinzhou
  8. 8.2.1 Xinzhou Company Information
  9. 8.2.2 Xinzhou Business Overview
  10. 8.2.3 Xinzhou EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Xinzhou EPA & DHA Omega-3 Product Portfolio
  12. 8.2.5 Xinzhou Recent Developments
  13. 8.3 TASA
  14. 8.3.1 TASA Company Information
  15. 8.3.2 TASA Business Overview
  16. 8.3.3 TASA EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 TASA EPA & DHA Omega-3 Product Portfolio
  18. 8.3.5 TASA Recent Developments
  19. 8.4 Solutex
  20. 8.4.1 Solutex Company Information
  21. 8.4.2 Solutex Business Overview
  22. 8.4.3 Solutex EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Solutex EPA & DHA Omega-3 Product Portfolio
  24. 8.4.5 Solutex Recent Developments
  25. 8.5 Skuny
  26. 8.5.1 Skuny Company Information
  27. 8.5.2 Skuny Business Overview
  28. 8.5.3 Skuny EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Skuny EPA & DHA Omega-3 Product Portfolio
  30. 8.5.5 Skuny Recent Developments
  31. 8.6 Sinomega
  32. 8.6.1 Sinomega Company Information
  33. 8.6.2 Sinomega Business Overview
  34. 8.6.3 Sinomega EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sinomega EPA & DHA Omega-3 Product Portfolio
  36. 8.6.5 Sinomega Recent Developments
  37. 8.7 Polaris
  38. 8.7.1 Polaris Company Information
  39. 8.7.2 Polaris Business Overview
  40. 8.7.3 Polaris EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Polaris EPA & DHA Omega-3 Product Portfolio
  42. 8.7.5 Polaris Recent Developments
  43. 8.8 Orkla Health
  44. 8.8.1 Orkla Health Company Information
  45. 8.8.2 Orkla Health Business Overview
  46. 8.8.3 Orkla Health EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Orkla Health EPA & DHA Omega-3 Product Portfolio
  48. 8.8.5 Orkla Health Recent Developments
  49. 8.9 Omega Protein
  50. 8.9.1 Omega Protein Company Information
  51. 8.9.2 Omega Protein Business Overview
  52. 8.9.3 Omega Protein EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Omega Protein EPA & DHA Omega-3 Product Portfolio
  54. 8.9.5 Omega Protein Recent Developments
  55. 8.10 OLVEA Fish Oils
  56. 8.10.1 OLVEA Fish Oils Company Information
  57. 8.10.2 OLVEA Fish Oils Business Overview
  58. 8.10.3 OLVEA Fish Oils EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 OLVEA Fish Oils EPA & DHA Omega-3 Product Portfolio
  60. 8.10.5 OLVEA Fish Oils Recent Developments
  61. 8.11 Nippon Suisan Kaisha
  62. 8.11.1 Nippon Suisan Kaisha Company Information
  63. 8.11.2 Nippon Suisan Kaisha Business Overview
  64. 8.11.3 Nippon Suisan Kaisha EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Nippon Suisan Kaisha EPA & DHA Omega-3 Product Portfolio
  66. 8.11.5 Nippon Suisan Kaisha Recent Developments
  67. 8.12 Maruha Nichiro Foods
  68. 8.12.1 Maruha Nichiro Foods Company Information
  69. 8.12.2 Maruha Nichiro Foods Business Overview
  70. 8.12.3 Maruha Nichiro Foods EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Maruha Nichiro Foods EPA & DHA Omega-3 Product Portfolio
  72. 8.12.5 Maruha Nichiro Foods Recent Developments
  73. 8.13 Marine Ingredients
  74. 8.13.1 Marine Ingredients Company Information
  75. 8.13.2 Marine Ingredients Business Overview
  76. 8.13.3 Marine Ingredients EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Marine Ingredients EPA & DHA Omega-3 Product Portfolio
  78. 8.13.5 Marine Ingredients Recent Developments
  79. 8.14 LYSI
  80. 8.14.1 LYSI Company Information
  81. 8.14.2 LYSI Business Overview
  82. 8.14.3 LYSI EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 LYSI EPA & DHA Omega-3 Product Portfolio
  84. 8.14.5 LYSI Recent Developments
  85. 8.15 Kinomega
  86. 8.15.1 Kinomega Company Information
  87. 8.15.2 Kinomega Business Overview
  88. 8.15.3 Kinomega EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Kinomega EPA & DHA Omega-3 Product Portfolio
  90. 8.15.5 Kinomega Recent Developments
  91. 8.16 KD Pharma
  92. 8.16.1 KD Pharma Company Information
  93. 8.16.2 KD Pharma Business Overview
  94. 8.16.3 KD Pharma EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 KD Pharma EPA & DHA Omega-3 Product Portfolio
  96. 8.16.5 KD Pharma Recent Developments
  97. 8.17 Hofseth BioCare
  98. 8.17.1 Hofseth BioCare Company Information
  99. 8.17.2 Hofseth BioCare Business Overview
  100. 8.17.3 Hofseth BioCare EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Hofseth BioCare EPA & DHA Omega-3 Product Portfolio
  102. 8.17.5 Hofseth BioCare Recent Developments
  103. 8.18 Golden Omega
  104. 8.18.1 Golden Omega Company Information
  105. 8.18.2 Golden Omega Business Overview
  106. 8.18.3 Golden Omega EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Golden Omega EPA & DHA Omega-3 Product Portfolio
  108. 8.18.5 Golden Omega Recent Developments
  109. 8.19 GC Rieber
  110. 8.19.1 GC Rieber Company Information
  111. 8.19.2 GC Rieber Business Overview
  112. 8.19.3 GC Rieber EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 GC Rieber EPA & DHA Omega-3 Product Portfolio
  114. 8.19.5 GC Rieber Recent Developments
  115. 8.20 EPAX
  116. 8.20.1 EPAX Company Information
  117. 8.20.2 EPAX Business Overview
  118. 8.20.3 EPAX EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 EPAX EPA & DHA Omega-3 Product Portfolio
  120. 8.20.5 EPAX Recent Developments
  121. 8.21 DSM
  122. 8.21.1 DSM Company Information
  123. 8.21.2 DSM Business Overview
  124. 8.21.3 DSM EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 DSM EPA & DHA Omega-3 Product Portfolio
  126. 8.21.5 DSM Recent Developments
  127. 8.22 Croda
  128. 8.22.1 Croda Company Information
  129. 8.22.2 Croda Business Overview
  130. 8.22.3 Croda EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Croda EPA & DHA Omega-3 Product Portfolio
  132. 8.22.5 Croda Recent Developments
  133. 8.23 Bioprocess Algae
  134. 8.23.1 Bioprocess Algae Company Information
  135. 8.23.2 Bioprocess Algae Business Overview
  136. 8.23.3 Bioprocess Algae EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Bioprocess Algae EPA & DHA Omega-3 Product Portfolio
  138. 8.23.5 Bioprocess Algae Recent Developments
  139. 8.24 BASF
  140. 8.24.1 BASF Company Information
  141. 8.24.2 BASF Business Overview
  142. 8.24.3 BASF EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 BASF EPA & DHA Omega-3 Product Portfolio
  144. 8.24.5 BASF Recent Developments
  145. 8.25 Auqi
  146. 8.25.1 Auqi Company Information
  147. 8.25.2 Auqi Business Overview
  148. 8.25.3 Auqi EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Auqi EPA & DHA Omega-3 Product Portfolio
  150. 8.25.5 Auqi Recent Developments
  151. 8.26 Anti-Cancer
  152. 8.26.1 Anti-Cancer Company Information
  153. 8.26.2 Anti-Cancer Business Overview
  154. 8.26.3 Anti-Cancer EPA & DHA Omega-3 Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Anti-Cancer EPA & DHA Omega-3 Product Portfolio
  156. 8.26.5 Anti-Cancer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 EPA & DHA Omega-3 Value Chain Analysis
  2. 9.1.1 EPA & DHA Omega-3 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 EPA & DHA Omega-3 Sales Mode & Process
  6. 9.2 EPA & DHA Omega-3 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 EPA & DHA Omega-3 Distributors
  9. 9.2.3 EPA & DHA Omega-3 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst